These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 27957479)
1. CXCL12 retargeting of an adenovirus vector to cancer cells using a bispecific adapter. Bhatia S; O'Bryan SM; Rivera AA; Curiel DT; Mathis JM Oncolytic Virother; 2016; 5():99-113. PubMed ID: 27957479 [TBL] [Abstract][Full Text] [Related]
2. CXCL12 Retargeting of an Oncolytic Adenovirus Vector to the Chemokine CXCR4 and CXCR7 Receptors in Breast Cancer. O'Bryan SM; Mathis JM J Cancer Ther; 2021 Jun; 12(6):311-336. PubMed ID: 34178415 [TBL] [Abstract][Full Text] [Related]
3. Adenovirus targeting to c-erbB-2 oncoprotein by single-chain antibody fused to trimeric form of adenovirus receptor ectodomain. Kashentseva EA; Seki T; Curiel DT; Dmitriev IP Cancer Res; 2002 Jan; 62(2):609-16. PubMed ID: 11809717 [TBL] [Abstract][Full Text] [Related]
4. Retargeting of adenoviral infection to melanoma: combining genetic ablation of native tropism with a recombinant bispecific single-chain diabody (scDb) adapter that binds to fiber knob and HMWMAA. Nettelbeck DM; Rivera AA; Kupsch J; Dieckmann D; Douglas JT; Kontermann RE; Alemany R; Curiel DT Int J Cancer; 2004 Jan; 108(1):136-45. PubMed ID: 14618628 [TBL] [Abstract][Full Text] [Related]
5. Adenovirus tumor targeting and hepatic untargeting by a coxsackie/adenovirus receptor ectodomain anti-carcinoembryonic antigen bispecific adapter. Li HJ; Everts M; Pereboeva L; Komarova S; Idan A; Curiel DT; Herschman HR Cancer Res; 2007 Jun; 67(11):5354-61. PubMed ID: 17545616 [TBL] [Abstract][Full Text] [Related]
7. Fibroblast growth factor 2 retargeted adenovirus has redirected cellular tropism: evidence for reduced toxicity and enhanced antitumor activity in mice. Gu DL; Gonzalez AM; Printz MA; Doukas J; Ying W; D'Andrea M; Hoganson DK; Curiel DT; Douglas JT; Sosnowski BA; Baird A; Aukerman SL; Pierce GF Cancer Res; 1999 Jun; 59(11):2608-14. PubMed ID: 10363982 [TBL] [Abstract][Full Text] [Related]
8. PolySia-Specific Retargeting of Oncolytic Viruses Triggers Tumor-Specific Immune Responses and Facilitates Therapy of Disseminated Lung Cancer. Kloos A; Woller N; Gürlevik E; Ureche CI; Niemann J; Armbrecht N; Martin NT; Geffers R; Manns MP; Gerardy-Schahn R; Kühnel F Cancer Immunol Res; 2015 Jul; 3(7):751-63. PubMed ID: 25701327 [TBL] [Abstract][Full Text] [Related]
9. Fiber manipulation and post-assembly nanobody conjugation for adenoviral vector retargeting through SpyTag-SpyCatcher protein ligation. Kadkhodazadeh M; Mohajel N; Behdani M; Baesi K; Khodaei B; Azadmanesh K; Arashkia A Front Mol Biosci; 2022; 9():1039324. PubMed ID: 36545512 [TBL] [Abstract][Full Text] [Related]
10. Targeting adenoviral vectors by using the extracellular domain of the coxsackie-adenovirus receptor: improved potency via trimerization. Kim J; Smith T; Idamakanti N; Mulgrew K; Kaloss M; Kylefjord H; Ryan PC; Kaleko M; Stevenson SC J Virol; 2002 Feb; 76(4):1892-903. PubMed ID: 11799184 [TBL] [Abstract][Full Text] [Related]
11. A human adenoviral vector with a chimeric fiber from canine adenovirus type 1 results in novel expanded tropism for cancer gene therapy. Stoff-Khalili MA; Rivera AA; Glasgow JN; Le LP; Stoff A; Everts M; Tsuruta Y; Kawakami Y; Bauerschmitz GJ; Mathis JM; Pereboeva L; Seigal GP; Dall P; Curiel DT Gene Ther; 2005 Dec; 12(23):1696-706. PubMed ID: 16034451 [TBL] [Abstract][Full Text] [Related]
12. Characterization of an Oncolytic Adenovirus Vector Constructed to Target the cMet Receptor. Sakr HI; Coleman DT; Cardelli JA; Mathis JM Oncolytic Virother; 2015; 4():119-132. PubMed ID: 26866014 [TBL] [Abstract][Full Text] [Related]
13. Combined fiber modifications both to target α(v)β(6) and detarget the coxsackievirus-adenovirus receptor improve virus toxicity profiles in vivo but fail to improve antitumoral efficacy relative to adenovirus serotype 5. Coughlan L; Vallath S; Gros A; Giménez-Alejandre M; Van Rooijen N; Thomas GJ; Baker AH; Cascalló M; Alemany R; Hart IR Hum Gene Ther; 2012 Sep; 23(9):960-79. PubMed ID: 22708837 [TBL] [Abstract][Full Text] [Related]